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Abstract
Background: Amebic liver abscess is a tropical disease with a wide spectrum of clinical
presentations. Given the often nonspecific nature of the complaints related to amebic abscess, a
retrospective review of patients with confirmed disease to recognize the most common patterns
of presentation is useful. Here, we study the clinical presentations of 62 Thai patients with amebic
liver abscess. We also compare the clinical presentations of Anti HIV seronegative and Anti HIV
seropositive patients.
Methods: A retrospective case review was carried out for 62 Thai patients who had been
diagnosed with amebic liver abscess. Clinical information was collected, including symptoms and
signs, location and number of abscesses. The Anti HIV serology laboratory investigation was also
reviewed.
Results: According to our study, the common clinical symptoms and signs are abdominal pain (85.5
%), fever and chills (74.2 %), and abdominal tenderness (69.4 %). The location of the abscess was
predominantly in the right lobe (74.2 %), and most of patients had a single abscess (77.4 %). Similar
trends in clinical presentations were observed in both Anti HIV seropositive and Anti HIV
seronegative subjects.
Conclusions: In conclusion, the clinical presentations of our amebic liver abscess patients were
similar to those in previous reports. A similarity to those in the pyogenic liver abscess patients can
be observed. Nevertheless, we could not detect important significant differences in the clinical
presentations between Anti HIV seropositive and Anti HIV seronegative groups of patients.
Background
Significant differences exist in the prevalence of most gas-
troenterological emergencies in tropical countries com-
pared with temperate countries [1]. Both ethnic and
environmental, often clearly defined geographically, fac-
tors are relevant. Amebiasis is a widespread parasitic dis-
ease caused by Entamoeba histolytica. This protozoan
organism is the third leading parasitic cause of death in
the developing world and is an important health risk to
travelers in endemic areas [2]. Amebiasis most commonly
results in asymptomatic colonization of the gastrointesti-
nal tract, but some patients may develop intestinal inva-
sive disease or extraintestinal disease. The most common
extraintestinal manifestation is that of a liver abscess [2].
This infection is common throughout the world and can
be associated with life-threatening consequences [2–5].
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ganism is carried through the blood to the liver where the
abscess is formed. Patients may or may not have symp-
toms of intestinal infection concurrently with liver abscess
[3–5]. This infection is present worldwide, but is most
common in tropical areas where crowded living condi-
tions and poor sanitation exist. Transmission occurs
through ingestion of cysts in fecally contaminated food or
water, use of human excrement as fertilizer, and person-
to-person contact. The incidence is about 1 out of 100,000
people for amebic liver abscess [3–5].
Here, the author reports the clinical presentations of the
amebic liver abscess in 62 Thai patients. The author also
presents some notification on the clinical presentations
among the HIV seropositive and HIV seronegative pa-
tients in our series.
Methods
The medical records of in-patients at the King Chulalong-
korn Memorial Hospital, Bangkok, Thailand, who had
been diagnosed as cases of amebic liver abscess, at some
time between January 1992 and December 2001, were ret-
rospectively reviewed. In each case, the abscess was diag-
nosed on the basis of the abscess cavity's appearance on
liver US and/or CT scans, and the recovery of pus from the
cavity during needle aspiration or surgery. The amebic liv-
er abscesses were diagnosed by 1) the identification of En-
tamoeba histolytica by microscopic examination of the pus
(n = 28) or 2) the positive results from Entamoeba histolyt-
ica indirect hemagglutination (IHA) test (n = 34).
The data collated from the records included the sex and
age of each patient, the Anti HIV serology status, the
symptoms and signs, the location and the number of ab-
scesses. All recorded data were collected and analyzed us-
ing descriptive statistics. Statistical significance level was
accepted at P-value equaled to 0.05. All the statistical anal-
yses in this study were made using SPSS 7.0 for Windows
Program.
Results
In the 10-year admission period investigated, 62 patients
were diagnosed as having amebic liver abscesses. In this
presentation, these 62 cases – 33 men (53.2 %) and 29
women (46.8 %) – had a mean (S.D.) age of 45.03
(19.92) years (range = 10–88 years). Of these 62 patients,
23 were Anti HIV seropositive (37.1 %) and 39 were Anti
HIV seronegative (62.9 %) (Table 1). Most of the patients
were suffering from abdominal pain (85.5 %), fever and
chills (74.2 %), and abdominal tenderness (69.4 %; Table
2).
The abscesses detected were usually restricted to the right
lobe of the liver (46 cases,74.2 %). Only seven (11.3 %)
of the cases only left-lobe abscesses and nine (14.5 %) had
both lobes affected. Among the Anti HIV seropositive
group, 17 had abscesses in the right lobe, 4 in the left and
2 in both. As for the Anti HIV seronegative group, 29 had
abscesses in the right lobe, 3 in the left and 7 in both.
Forty-eight of the cases (77.4 %) had a single abscess and
14 (22.6 %) had multiple abscesses. Among the Anti HIV
seropositive group, 18 had a single abscess and 5 had mul-
tiple abscesses. As for the Anti HIV seronegative group, 30
had a single abscess and 9 had multiple abscesses. There is
no significant difference in the proportion of cases with
multiple abscesses between both groups (Proportional Z
test, P > 0.05).
Discussion
Liver abscess is an important tropical gastrointestinal dis-
order [1,6]. The liver abscess is classified mainly into pyo-
genic and amebic types. Concerning liver amebiasis, the
infection starts with an ingestion of amebic cysts, which,
after excystation form trophozoits in the small intestine,
colonize the bowel lumen and invade the intestinal epi-
thelium resulting in amebic colitis. The spreading to the
liver and formation of amebic liver abscesses occurs in
one third of the cases [3–5]. Amebic liver abscess have a
good prognosis when treated with metronidazole [2,5].
An early diagnosis and treatment is therefore important.
The diagnosis is made by demonstration of Entamoeba his-
tolytica cysts or ameba in the pus or positive serology [2,5].
Table 1: Patients' characteristics in 62 patients with amebic liver abscess
Patients' characteristics Group
All (n = 62) Anti HIV seropositive (n = 23) Anti HIV seronegative (n = 39)
Age (years) 45.03 ± 19.92 45.83 ± 16.65 44.56 ± 21.81
Sex (Male: female ratio) 33:29 10 :13 23 : 16
Duration of clinical presentations (days) 7.31 ± 0.82 7.30 ± 0.82 7.33 ± 0.83Page 2 of 4
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presentations from no complaints to arrest [7–11]. Mal-
nutrition, liver cirrhosis and alcoholism have been report-
ed to be an important factor in causing the infected person
to have more severe clinical presentations [2–5]. Given
the often nonspecific nature of the complaints related to
an amebic abscess, a retrospective review of patients with
confirmed disease to recognize the most common pat-
terns of presentation is useful [7–11]. Nevertheless, there
had been no study comparing the clinical presentations of
the amebic liver abscess in Anti HIV seronegative compar-
ing to Anti HIV seropositive cases. Therefore, we designed
this study to review the clinical presentations of the Thai
patients with amebic liver abscess. A comparison of clini-
cal presentations between Anti HIV seronegative and Anti
HIV seropositive cases was also made.
Concerning the Anti HIV serology, 23 cases were Anti HIV
seropositive (37.1 %) and 39 were Anti HIV seronegative
(62.9 %). The average age of both groups was not signifi-
cantly different (Unpaired T-test, P > 0.05). The propor-
tion of male or female subjects in both group was not
statistically significantly different (Proportional Z test, P >
0.05). There was no significant difference in the duration
of clinical presentations between both groups either (Un-
paired T-test, P > 0.05). Of interest, generally, invasive
amebiasis as amebic liver abscess rarely occurs in HIV se-
ropositive individuals and has not been regarded as a dis-
order for concomitant HIV infection. One of the possible
explanations is the fact that most of the previous studies
were in temperate countries, which is not the endemic
area of amebiasis [12]. Our findings support the observa-
tion of Liu that amebic liver abscess can be an important
gastrointestinal problem for HIV infection in the Far East
[13].
According to our series, the findings about the clinical
symptoms and signs in our patients were similar to those
in the previous reports [2,5,7]. The three most common
findings are abdominal pain (85.5 %), fever and chills
(74.2 %), and abdominal tenderness (69.4 %). These
three common findings are present in both Anti HIV sero-
positive and Anti HIV seronegative cases (Table 1). These
clinical manifestations are similar to those in pyogenic liv-
er abscess patients [8–11].
Like in the previous studies [2,5,7], the abscesses were lo-
cated predominantly in the right lobe of the liver (74.2
%). Regarding the number of abscesses, most of our pa-
tient had single abscess (77.4 %). These findings are sim-
ilar to the reported characters among the pyogenic liver
abscess patients [8–11]. In addition, these trends are sim-
ilar for both Anti HIV seropositive and Anti HIV seroneg-
ative.
In conclusion, the clinical presentations of our amebic liv-
er abscess patients were similar to those in previous re-
ports. The similarity to those in the pyogenic liver abscess
patients can also be observed. Nevertheless, we could not
demonstrate important significant difference of the clini-
cal presentations between Anti HIV seropositive and Anti
HIV seronegative groups in our patients.
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Table 2: Clinical presentations in 62 patients with amebic liver abscess
Clinical presentations Number of patients (%)
All Anti HIV seropositive Anti HIV seronegative
Abdominal pain 53 (85.5 %) 14 (22.6 %) 39 (62.9 %)
Fever and chills 46 (74.2 %) 18 (29.0 %) 28 (45.2 %)
Abdominal tenderness 43 (69.4 %) 14 (22.6 %) 29 (46.8 %)
Anorexia 39 (62.9 %) 14 (22.6 %) 25 (40.3 %)
Hepatomegaly 37 (59.7 %) 14 (22.6 %) 23 (37.1 %)
Jaundice 25 (40.3 %) 9 (14.5 %) 16 (25.8 %)
Nausea 23 (37.1 %) 8 (12.9 %) 15 (24.2 %)
Malaise and weakness 14 (22.6 %) 4 (6.5 %) 10 (16.1 %)
Body weight loss 10(16.1 %) 4 (6.5 %) 6 (9.6 %)
Dyspnea 7 (11.3 %) 2 (3.2 %) 5 (8.1 %)
* There is no significant difference in the proportion of patients with each clinical manifestation between Anti HIV seropositive and Anti HIV seron-
egative groups.Page 3 of 4
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